Advanced company searchLink opens in new window

BIRMINGHAM NEWMEDICA LIMITED

Company number 13992467

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
17 Oct 2024 AA Audit exemption subsidiary accounts made up to 29 February 2024
17 Oct 2024 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 29/02/24
13 Apr 2024 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 29/02/24
13 Apr 2024 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 29/02/24
21 Mar 2024 CS01 Confirmation statement made on 20 March 2024 with updates
30 Oct 2023 AA Audit exemption subsidiary accounts made up to 28 February 2023
30 Oct 2023 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 28/02/23
05 Jul 2023 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 28/02/23
05 Jul 2023 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 28/02/23
24 Mar 2023 CS01 Confirmation statement made on 20 March 2023 with updates
23 Mar 2023 AP01 Appointment of Mr Velota Ching Tak Sung as a director on 9 January 2023
10 Jan 2023 PSC05 Change of details for New Medical Systems Limited as a person with significant control on 9 January 2023
10 Jan 2023 AP01 Appointment of Mr Ashutosh Sharma as a director on 9 January 2023
10 Jan 2023 AP01 Appointment of Mr Satya Sai Prasad Kolli as a director on 9 January 2023
10 Jan 2023 AP01 Appointment of Mr Aaron Thye Wang Ng as a director on 9 January 2023
10 Jan 2023 AP01 Appointment of Mrs Rachel Naomi Hill as a director on 9 January 2023
09 Jan 2023 SH01 Statement of capital following an allotment of shares on 9 January 2023
  • GBP 120.5
09 Jan 2023 SH01 Statement of capital following an allotment of shares on 9 January 2023
  • GBP 108.5
09 Jan 2023 SH01 Statement of capital following an allotment of shares on 9 January 2023
  • GBP 96.5
09 Jan 2023 SH01 Statement of capital following an allotment of shares on 9 January 2023
  • GBP 84.5
09 Jan 2023 SH01 Statement of capital following an allotment of shares on 9 January 2023
  • GBP 72.5
09 Jan 2023 SH01 Statement of capital following an allotment of shares on 9 January 2023
  • GBP 60.5
09 Jan 2023 TM01 Termination of appointment of Rebecca Lucy Lythe as a director on 9 January 2023
09 Jan 2023 TM01 Termination of appointment of Giles Stuart Rutherford Edmonds as a director on 9 January 2023
12 May 2022 AA01 Current accounting period shortened from 31 March 2023 to 28 February 2023